Category Archives: NIAID

  1. PrEP: A Possible Approval Like No Other

    Via Poz, by Tim Horn The AIDS Healthcare Foundation began a paid advertisement campaign urging Gilead Sciences to refrain from seeking approval from the U.S. Food and Drug Administration for Truvada for use of the combination tablet as HIV prevention, in an approach known as pre-exposure prophylaxis, or PrEP. The ads were met by an outcry from the Read More >>

    clinical trials, HIV Prevention Justice Alliance, HIV/AIDS, Infections, iPrEx, MSM, NIAID, NIH, placebo, PrEP, Truvada
  2. Restructuring the NIAID HIV/AIDS Clinical Trials Networks

    From the National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Disease (NIAID) is currently planning for the future of NIAID’s HIV/AIDS clinical trial networks. The following links connect to background information discussing the process, scientific priorities, structural components and collaborative opportunities with respect to the restructuring: Restructuring NIAID’s HIV/AIDS Clinical Trials Read More >>

    advocacy, clinical trials, NIAID, NIH, research
  3. Fauci Validates Need for RECTAL Microbicides

    Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Black HIV/AIDS Awareness and Information Day February 7, 2009 Excerpt: “Treatment is no substitute for prevention, however. NIAID-funded investigators are working to develop and validate new methods to protect against HIV infection, including microbicides that could be Read More >>

    Dr. Anthony Fauci, HIV transmission, HIV/AIDS policy, new prevention technologies, NIAID, NIH, PrEP, rectal microbicide, vaccine, vaginal microbicide
  4. Protecting Women from HIV–Docs Hopeful About Microbicides

    It is a real shame that this Scientific American article, posted today, ignores rectal microbicides and the prevention needs of gay men and other men who have sex with men. I urge IRMA members to read the item and post a comment (as I did), advocating for accuracy and inclusion when we discuss the important research happening Read More >>

    men, NIAID, NIH, rectal microbicide, research, vaginal microbicide, women
  5. The Future of Rectal Microbicides – an IRMA Q&A with Dr. Jim Turpin

    Each step is part of the waft and weave leading to a safe, acceptable and effective rectal microbicide. IRMA asks Jim Turpin, Ph.D., Microbicide Research Branch*, about the National Institutes of Health and its commitment to rectal microbicides IRMA: Why are rectal microbicides an important part of the NIAID/NIH prevention portfolio? Dr. Turpin: Rectal microbicides are important Read More >>

    behavioral research, CDC, DAIDS, Dr. Jim Turpin, men, MSM, new prevention technologies, NIAID, NIH, PrEP, research, women